Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis [3]

Annals of Neurology

Volumn 50, Issue 2, 2001, Pages 275-

  Van Veen, Tineke ^a,b   Bart A Crusius, J ^a   Schrijver, Hans M ^a   Bouma, Gerd ^a   Killestein, Joep ^a   Van Winsen, Lisa ^a   Salvador Pena A ^a   Polman, Chris H ^a   Uitdehaag, Bernard M J ^a  

^a Department of Neurology ^*  (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ALLELISM; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HOMOZYGOSITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NETHERLANDS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0034903707     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1107     Document Type: Letter

References (5)

1. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis
2. Interleukin-12
3. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12p40 subunit
4. Linkage disequilibrium of a type I diabetes susceptibility locus with a regulatory IL12B allele
5. Genetic polymorphism of IL-12p40 gene in immune-mediated disease